# Cytochrome P450 2D6 (CYP 450 2D6) Genotype and Flecainide Efficacy

> **NCT00945867** · — · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00945867
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945867, "Cytochrome P450 2D6 (CYP 450 2D6) Genotype and Flecainide Efficacy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00945867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*